… IgG1 antibodies that targets the spike protein of SARS-CoV-2, … shown to reduce viral loads
of SARS-CoV-2 and improved viral … Each patient received a combination dose of 1200 mg of …

… Casirivimab/imdevimab (Ronapreve™; REGEN-COV™) is a co-packaged combination of
two neutralizing immunoglobulin gamma 1 (IgG1) human monoclonal antibodies (casirivimab …

… O’Brien and colleagues examined the efficacy of REGEN-COV administration as post-… of
SARS-CoV-2-infected individuals. REGEN-COV is a combination of two monoclonal antibodies, …

… REGEN-COV, the cocktail of monoclonal antibodies casirivimab and imdevimab, was given
Emergency Use Authorization (EUA) for the treatment of patients with mild-moderate COVID-…

… and imdevimab (REGEN-COV) monoclonal antibodies in combination with remdesivir resulted
… The REGEN-COV antibody cocktail may improve the outcome of SARS-CoV-2 infection in …

… In vitro, a combination of casirivimab and imdevimab induced antibody-mediated … baseline
antibody status were randomly assigned to receive usual treatment with REGEN-COV or …

… antibodies. These results suggest that the presence of heterodimers in co-formulated
REGEN-COV Ⓡ … Citation17 This combination of SEC and HIC has been demonstrated to enable …

… [10] in hospitalized patients treated with REGEN-COV2 versus … REGEN-COV2 combination
antibody therapy showed … have not developed an antibody response to SARS-CoV-2 infection…

… monoclonal antibody combination of casirivimab and imdevimab (REGEN-COV) has been
… This report highlights the importance of the early use of REGEN-COV in patients with COVID…

… The REGEN-COV trials assessed the mAb combination casirivimab–imdevimab
delivered intravenously in outpatients. The phase 2 trial showed that participants who were …